Vinod P Balachandran Selected Research

Neoadjuvant Therapy

1/2023	Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma.
10/2022	Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy.
6/2022	Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma.
1/2019	Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod P Balachandran Research Topics

Disease

47	Neoplasms (Cancer) 04/2024 - 08/2011
24	Neoplasm Metastasis (Metastasis) 12/2023 - 05/2017
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 08/2011
8	Adenocarcinoma 06/2023 - 10/2017
5	Cholangiocarcinoma 02/2024 - 01/2020
4	Pancreatic Neoplasms (Pancreatic Cancer) 06/2023 - 10/2017
3	Inflammation (Inflammations) 01/2020 - 02/2010
2	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 10/2017
2	Margins of Excision 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2019
2	Communicable Diseases (Infectious Diseases) 01/2021 - 11/2017
2	Fibrosis (Cirrhosis) 01/2020 - 05/2017
2	Hypophosphatemia 02/2019 - 10/2017
2	Surgical Wound Infection 01/2019 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2018 - 05/2017
2	Reperfusion Injury 02/2010 - 02/2010
2	Ischemia 02/2010 - 02/2010
1	Digestive System Diseases 01/2024
1	Carcinogenesis 01/2022
1	Cysts 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	COVID-19 01/2022
1	Neoplasms, Cystic, Mucinous, and Serous 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Abscess 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2019
1	Infections 01/2019
1	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2018
1	Liver Failure 10/2017
1	Familial Hypophosphatemia (Phosphate Diabetes) 10/2017
1	Pancreatic Cyst 10/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2017

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
8	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 08/2011
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2020
4	Gemcitabine FDA Link 01/2024 - 01/2020
4	AntigensIBA 10/2022 - 11/2017
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 02/2010
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Carcinoembryonic AntigenIBA 01/2020 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 10/2023
2	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2018
2	VaccinesIBA 06/2023 - 01/2022
2	folfirinoxIBA 01/2023 - 03/2022
2	Floxuridine (FUdR)FDA LinkGeneric 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 02/2010
2	Phosphates (Orthophosphate)IBA 02/2019 - 10/2017
2	Peptides (Polypeptides)IBA 11/2017 - 11/2017
2	Phosphotransferases (Kinase)IBA 01/2014 - 10/2013
2	Oncogene Proteins (Oncogene Protein)IBA 12/2013 - 08/2011
2	Interleukin-10 (Interleukin 10)IBA 03/2011 - 02/2010
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	Toll-Like Receptor 2IBA 04/2024
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2024
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	CarbohydratesIBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 06/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	TESIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	nasIBA 01/2020
1	Circulating Tumor DNAIBA 06/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	pasireotideIBA 01/2019
1	Bacitracin (Baci-Rx)FDA LinkGeneric 01/2019
1	SolutionsIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	VLX600IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	EpitopesIBA 11/2017
1	AlbuminsIBA 11/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2017
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2017
1	Fetal Proteins (Fetoprotein)IBA 05/2017
1	TankyrasesIBA 01/2017
1	G007-LKIBA 01/2017

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2024 - 05/2017
15	Therapeutics 02/2024 - 08/2011
7	Infusion Pumps (Infusion Pump) 01/2024 - 01/2020
5	Hepatectomy 11/2022 - 10/2017
5	Immunotherapy 01/2022 - 08/2011
4	Neoadjuvant Therapy 01/2023 - 01/2019
4	Pancreaticoduodenectomy 01/2021 - 01/2017
3	Induction Chemotherapy 01/2023 - 12/2021
3	Transplantation 10/2022 - 09/2010
2	Pancreatectomy 01/2019 - 10/2017
1	Radiotherapy 12/2021
1	Adjuvant Chemotherapy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Patient Care Bundles 01/2019
1	Precision Medicine 01/2019
1	Cytoreduction Surgical Procedures 01/2018